TrajVis: a visual clinical decision support system to translate artificial intelligence trajectory models in the precision management of chronic kidney disease

Zuotian Li,Xiang Liu,Ziyang Tang,Pengyue Zhang,Nanxin Jin,Michael Eadon,Qianqian Song,Yingjie Chen,Jing Su
2024-01-16
Abstract:Objective: Our objective is to develop and validate TrajVis, an interactive tool that assists clinicians in using artificial intelligence (AI) models to leverage patients' longitudinal electronic medical records (EMR) for personalized precision management of chronic disease progression. Methods: We first perform requirement analysis with clinicians and data scientists to determine the visual analytics tasks of the TrajVis system as well as its design and functionalities. A graph AI model for chronic kidney disease (CKD) trajectory inference named DEPOT is used for system development and demonstration. TrajVis is implemented as a full-stack web application with synthetic EMR data derived from the Atrium Health Wake Forest Baptist Translational Data Warehouse and the Indiana Network for Patient Care research database. A case study with a nephrologist and a user experience survey of clinicians and data scientists are conducted to evaluate the TrajVis system. Results: The TrajVis clinical information system is composed of four panels: the Patient View for demographic and clinical information, the Trajectory View to visualize the DEPOT-derived CKD trajectories in latent space, the Clinical Indicator View to elucidate longitudinal patterns of clinical features and interpret DEPOT predictions, and the Analysis View to demonstrate personal CKD progression trajectories. System evaluations suggest that TrajVis supports clinicians in summarizing clinical data, identifying individualized risk predictors, and visualizing patient disease progression trajectories, overcoming the barriers of AI implementation in healthcare. Conclusion: TrajVis bridges the gap between the fast-growing AI/ML modeling and the clinical use of such models for personalized and precision management of chronic diseases.
Human-Computer Interaction
What problem does this paper attempt to address?
The paper attempts to address the problem of how to utilize Artificial Intelligence (AI) models and Electronic Medical Records (EMR) data to achieve precise management of Chronic Kidney Disease (CKD). Specifically, the researchers developed a visualization clinical decision support system called TrajVis, aimed at helping doctors use AI models to analyze patients' longitudinal electronic medical records, thereby achieving personalized and precise disease management. ### Main Issues: 1. **Delayed Recognition of Disease Progression**: Traditional clinical indicators such as estimated Glomerular Filtration Rate (eGFR) and Urine Albumin-to-Creatinine Ratio (UACR) have issues with delayed recognition when monitoring CKD progression, leading to missed optimal intervention times. 2. **Overdiagnosis**: Fluctuations in key clinical indicators may lead to overdiagnosis. 3. **Black Box Nature of AI Models**: Although AI models perform well in predicting disease progression, their black box nature makes it difficult for doctors to understand and trust the results, hindering their clinical application. ### Solution: - **TrajVis System**: Through visualization technology, the TrajVis system presents the AI model's prediction results in an intuitive way to doctors, helping them better understand patients' disease progression trajectories and risk factors. - **Multi-View Design**: The system includes four main panels: - **Patient View**: Displays the patient's basic information and clinical indicator trends. - **Trajectory View**: Visualizes the patient's medical history in the context of the overall population, showing three main CKD progression trajectories (healthy, late progression, early progression). - **Clinical Indicator View**: Shows trends in the patient's visit patterns, vital signs, and lab test results, annotating clinical evidence related to AI predictions. - **Analysis View**: Displays trends in eGFR levels with age for different trajectory cohorts and the likelihood of the patient following each trajectory. ### Evaluation Methods: - **Case Study**: Evaluates the effectiveness of the TrajVis system through real cases. - **User Survey**: Surveys doctors and data scientists on their user experience and satisfaction with the system. ### Conclusion: The TrajVis system effectively bridges the gap between rapidly developing AI/ML modeling and clinical application, helping doctors better utilize AI models for personalized and precise management of chronic diseases.